Articles From: Harris Poll EquiTrend®: First-Ever Regional Grocery Store Brand of the Year Highlights Traditional Grocery Stores to Harvard Apparatus Regenerative Technology Obtains Orphan Drug Designation from U.S. Food and Drug Administration for HART-Trachea


2014/7/21
Hy-Vee, Publix, Wegmans and Costco Receive Highest Brand Equity Scores NEW YORK , July 21, 2014 /PRNewswire/ -- The 2014 Harris Poll EquiTrend® (EQ) study, which measures brand equity for more than 1,500 brands across 170 categories, finds traditional grocery store brands rank highest overall in three of the four regions surveyed.
Sign-up for Harris Poll EquiTrend®: First-Ever Regional Grocery Store Brand of the Year Highlights Traditional Grocery Stores investment picks
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises BHC on its Sale to Behrman Capital investment picks
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Callison, LLC on its Pending Sale to ARCADIS investment picks
2014/9/4
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Capstone Logistics, LLC on its Sale to The Jordan Company investment picks
2014/6/27
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Double Negative on its Pending Merger with Prime Focus World investment picks
2014/8/27
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Galson Laboratories on its Sale to SGS SA investment picks
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises IPA, LLC on its Sale to Roper Industries investment picks
2014/8/21
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Mister Car Wash on its Sale to Leonard Green & Partners, LP investment picks
2014/8/1
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Ross Aviation on its Sale to Landmark Aviation investment picks
2014/6/19
Harris Williams & Co.
Sign-up for Harris Williams & Co. Advises Wencor Group, LLC on its Sale to Warburg Pincus LLC investment picks
2014/9/4
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Harry & David (Other OTC: HARR) concerning the acquisition by 1-800FLOWERS.com. Under the terms of the agreement, 1-800FLOWERS will acquire Harry & David for approximately $143 million dollars.
Sign-up for HARRY & DAVID SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by 1-800FLOWERS.com investment picks
2014/8/19
Harry Steele acquires additional shares of Newfoundland Capital Corporation Limited Canada NewsWire DARTMOUTH, NS , Aug.
Sign-up for Harry Steele acquires additional shares of Newfoundland Capital Corporation Limited investment picks
CAMP HILL, Pa., July 31, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of Harsco Corporation (NYSE:HSC) has declared a regular quarterly cash dividend of $0.205 per share, or $0.82 per share on an annualized basis, payable November 15, 2014 to shareholders of record at the close of business on October 15, 2014.
Sign-up for Harsco Corporation Declares Regular Quarterly Cash Dividend investment picks
Adjusted Operating Income within Guidance; Organic Growth and Favorable Product Mix in Industrial and Rail Offset Bad Debt Costs in Metals & Minerals Project Orion Execution Progressing Rapidly with Phase I Benefits Expected to Reach High-end of Expectations Company Narrows 2014 Adjusted Operating Income Guidance to Range of $170 million to $180 million CAMP HILL, Pa., Aug.
Sign-up for Harsco Corporation Reports Second Quarter 2014 Results investment picks
CAMP HILL, Pa., July 9, 2014 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE:HSC) today announced the following schedule and teleconference information for its second quarter 2014 earnings release.
Sign-up for Harsco Corporation to Release Second Quarter 2014 Results and Hold Conference Call on August 7, 2014 investment picks
CAMP HILL, Pa., July 1, 2014 (GLOBE NEWSWIRE) -- Diversified global industrial company Harsco Corporation (NYSE:HSC) announced today its second major railway track and infrastructure maintenance equipment award from SBB, the federal railway system of Switzerland.
Sign-up for Harsco Secures Its Second $100 Million+ Railway Maintenance Equipment Contract in Switzerland investment picks
RF Micro Devices, Inc. (Nasdaq: RFMD) and TriQuint Semiconductor, Inc. (Nasdaq: TQNT) announced today that the applicable waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in relation to the previously announced business combination between RFMD and TriQuint, expired as of 11:59 p.m. EDT on June 13, 2014, with no action by the Federal Trade Commission or the Department of Justice.
Sign-up for Hart-Scott-Rodino Waiting Period Expires for RFMD and TriQuint Business Combination investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961581001&sourceType=1 http://www.ccnmatthews.com/logos/20091123-Hartco_200.jpg MONTREAL, QUEBEC --
Sign-up for Hartco Announces 2014 Second Quarter Results investment picks
2014/8/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0963653001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Announces Closing of Private Placement investment picks
2014/7/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960529001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Announces Final Closing of Private Placement Provides Exploration Update investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140670&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Announces $20 Million Stock Repurchase Program investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133458&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Announces 2nd Quarter 2014 Financial Results Conference Call investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134918&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Harte Hanks Declares Regular Quarterly Dividend investment picks
http://media.marketwire.com/attachments/201310/197741_HHlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134457&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Harte Hanks Reports Second Quarter Results investment picks
The Hartford Steam Boiler Inspection and Insurance Company (HSB), a leading engineering and technical risk insurer, and Guidewire Software, Inc. (NYSE:GWRE), a provider of software products to Property/Casualty (P/C) insurers, today announced that HSB has successfully deployed Guidewire ClaimCenter® as its new platform for claims management.
Sign-up for Hartford Steam Boiler Deploys Guidewire System for Claims Management investment picks
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), or HART, a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the HART-Trachea, which is intended to replace or repair a trachea that has been severely damaged by either trachea cancer or physical trauma.
Sign-up for Harvard Apparatus Regenerative Technology Obtains Orphan Drug Designation from U.S. Food and Drug Administration for HART-Trachea investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Harris Poll EquiTrend®: First-Ever Regional Grocery Store Brand of the Year Highlights Traditional Grocery Stores to Harvard Apparatus Regenerative Technology Obtains Orphan Drug Designation from U.S. Food and Drug Administration for HART-Trachea
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices